• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环磷酸腺苷生成不足:终末期心力衰竭患者收缩功能障碍重要病因的药理学证据

Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.

作者信息

Feldman M D, Copelas L, Gwathmey J K, Phillips P, Warren S E, Schoen F J, Grossman W, Morgan J P

出版信息

Circulation. 1987 Feb;75(2):331-9. doi: 10.1161/01.cir.75.2.331.

DOI:10.1161/01.cir.75.2.331
PMID:2433073
Abstract

We studied the effects of different classes of inotropic drugs on human working myocardium in vitro that was isolated from the hearts of patients with end-stage heart failure, and compared the responses to these drugs with those noted in muscles from nonfailing control hearts. Although peak isometric force generated in response to increased extracellular calcium reached control levels in the muscles from patients with heart failure, the time course of contraction and rate of relaxation were greatly prolonged. The inotropic effectiveness of the beta-adrenergic agonist isoproterenol and the phosphodiesterase inhibitors milrinone, caffeine, and isobutylmethylxanthine was markedly reduced in muscles from the patients with heart failure. In contrast, the effectiveness of inotropic stimulation with acetylstrophanthidin and the adenylate cyclase activator forskolin was preserved. After a minimally effective dose of forskolin was given to elevate intracellular cyclic AMP levels, the inotropic responses of muscles from the failing hearts to phosphodiesterase inhibitors were markedly potentiated. These data indicate that an abnormality in cyclic AMP production may be a fundamental defect present in patients with end-stage heart failure that can markedly diminish the effectiveness of agents that depend on generation of this nucleotide for production of a positive inotropic effect.

摘要

我们研究了不同种类的正性肌力药物对体外培养的人类工作心肌的作用,这些心肌取自终末期心力衰竭患者的心脏,并将这些药物的反应与取自非衰竭对照心脏的肌肉中的反应进行了比较。尽管心力衰竭患者肌肉中因细胞外钙增加而产生的等长收缩峰值力达到了对照水平,但收缩的时间进程和舒张速率却大大延长。β-肾上腺素能激动剂异丙肾上腺素以及磷酸二酯酶抑制剂米力农、咖啡因和异丁基甲基黄嘌呤在心力衰竭患者肌肉中的正性肌力作用明显降低。相比之下,毒毛花苷和腺苷酸环化酶激活剂福斯可林的正性肌力刺激作用得以保留。给予最小有效剂量的福斯可林以提高细胞内环磷酸腺苷(cAMP)水平后,衰竭心脏肌肉对磷酸二酯酶抑制剂的正性肌力反应明显增强。这些数据表明,环磷酸腺苷产生异常可能是终末期心力衰竭患者存在的一个基本缺陷,这可能会显著降低依赖该核苷酸产生正性肌力作用的药物的有效性。

相似文献

1
Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.环磷酸腺苷生成不足:终末期心力衰竭患者收缩功能障碍重要病因的药理学证据
Circulation. 1987 Feb;75(2):331-9. doi: 10.1161/01.cir.75.2.331.
2
Decreased inotropic but relatively preserved relaxation response to cyclic adenosine monophosphate-dependent agents in myopathic human myocardium.在患有心肌病的人类心肌中,对环磷酸腺苷依赖性药物的变力作用降低,但舒张反应相对保留。
J Card Fail. 1996 Dec;2(4):285-92. doi: 10.1016/s1071-9164(96)80015-7.
3
Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure.细胞内钙处理异常是心力衰竭患者心室心肌收缩和舒张功能障碍的主要原因。
Circulation. 1990 Feb;81(2 Suppl):III21-32.
4
Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.强心喹啉酮衍生物Y-20487对异丙肾上腺素诱导的大鼠心室肌正性肌力作用及环磷酸腺苷积累的影响:与咯利普兰、Ro 20-1724、米力农和异丁基甲基黄嘌呤的比较。
J Cardiovasc Pharmacol. 1992;20(5):715-22.
5
Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.与非衰竭人类心肌标本相比,磷酸二酯酶III抑制剂匹莫苯丹、阿迪苯丹和沙替利酮在衰竭心肌中强心作用减弱的潜在机制。
Naunyn Schmiedebergs Arch Pharmacol. 1991 Jul;344(1):90-100. doi: 10.1007/BF00167387.
6
The effects of milrinone and piroximone on intracellular calcium handling in working myocardium from the ferret.米力农和吡罗昔酮对雪貂工作心肌细胞内钙处理的影响。
Br J Pharmacol. 1985 May;85(1):97-108. doi: 10.1111/j.1476-5381.1985.tb08835.x.
7
The effect of positive inotropes on the failing human myocardium.正性肌力药物对衰竭的人体心肌的作用。
Cardiology. 1997;88 Suppl 2:7-11. doi: 10.1159/000177478.
8
Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation.衰竭的人类心脏对异丙肾上腺素和米力农的敏感性降低与β-肾上腺素能受体下调有关。
J Cardiovasc Pharmacol. 1988 Dec;12(6):726-32. doi: 10.1097/00005344-198812000-00015.
9
Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.几种新型强心药物对心脏环磷酸腺苷代谢的影响。
Biochem Pharmacol. 1986 Apr 1;35(7):1113-21. doi: 10.1016/0006-2952(86)90147-4.
10
Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.环核苷酸磷酸二酯酶抑制剂对人和豚鼠心肌细胞β-肾上腺素能受体脱敏的不完全逆转作用
Br J Pharmacol. 1993 Aug;109(4):1071-8. doi: 10.1111/j.1476-5381.1993.tb13731.x.

引用本文的文献

1
Studies on the mechanisms of action of MR33317.关于 MR33317 作用机制的研究。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8893-8902. doi: 10.1007/s00210-024-03226-0. Epub 2024 Jun 10.
2
Effects of hallucinogenic drugs on the human heart.致幻药物对人体心脏的影响。
Front Pharmacol. 2024 Feb 2;15:1334218. doi: 10.3389/fphar.2024.1334218. eCollection 2024.
3
The therapeutic potential of targeting cardiac RGS4.靶向心脏 RGS4 的治疗潜力。
Ther Adv Cardiovasc Dis. 2023 Jan-Dec;17:17539447231199350. doi: 10.1177/17539447231199350.
4
Clinical pharmacology of cardiac cyclic AMP in human heart failure: too much or too little?人心力衰竭中心脏环磷酸腺苷的临床药理学:过多还是过少?
Expert Rev Clin Pharmacol. 2023 Jul-Dec;16(7):623-630. doi: 10.1080/17512433.2023.2233891. Epub 2023 Jul 12.
5
Cardiac RGS Proteins in Human Heart Failure and Atrial Fibrillation: Focus on RGS4.心脏衰竭和心房颤动中的心脏 RGS 蛋白:聚焦于 RGS4。
Int J Mol Sci. 2023 Mar 24;24(7):6136. doi: 10.3390/ijms24076136.
6
Levosimendan increases the phosphorylation state of phospholamban in the isolated human atrium.左西孟旦增加了分离的人左心房中磷蛋白磷酸化状态。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Apr;396(4):669-682. doi: 10.1007/s00210-022-02348-7. Epub 2022 Nov 29.
7
Calcium and Heart Failure: How Did We Get Here and Where Are We Going?钙与心力衰竭:我们是如何走到这一步的,以及我们的未来方向在哪里?
Int J Mol Sci. 2021 Jul 9;22(14):7392. doi: 10.3390/ijms22147392.
8
Association of preoperative duration of inotropy on prevalence of right ventricular failure following LVAD implantation.左心室辅助装置植入术后正性肌力药物使用时间与右心衰竭发生率的相关性研究。
ESC Heart Fail. 2020 Aug;7(4):1949-1955. doi: 10.1002/ehf2.12791. Epub 2020 Jun 11.
9
A PDE3A Promoter Polymorphism Regulates cAMP-Induced Transcriptional Activity in Failing Human Myocardium.PDE3A 启动子多态性调节衰竭人类心肌中 cAMP 诱导的转录活性。
J Am Coll Cardiol. 2019 Mar 19;73(10):1173-1184. doi: 10.1016/j.jacc.2018.12.053.
10
Mouse Cardiac Pde1C Is a Direct Transcriptional Target of Pparα.小鼠心脏 PDE1C 是 PPARα 的直接转录靶标。
Int J Mol Sci. 2018 Nov 22;19(12):3704. doi: 10.3390/ijms19123704.